William Franklin Hoffman MD PhD
Professor, Psychiatry, Behavioral Neuroscience, Oregon Health and Science University School of Medicine
Join to View Full Profile
3710 Sw Us Veterans Hospital RdMental Health Division P35cPortland, OR 97239
Phone+1 503-273-5049
Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a Professor of Psychiatry and Behavioral Neuroscience at OHSU and a Staff Physician at the VA Portland Health Care System. I received a Bachelor of Science in Biochemistry at The Ohio State University and then completed a Ph.D. in Physical Chemistry at the University of Wisconsin, Madison. After graduate school, I attended medical school at UW Madison. I completed residency in Psychiatry at OHSU and then joined the staff at OHSU and the Portland VA . My research interests combine my training in physical chemistry and biological psychiatry. I use neuroimaging to investigate causes and treatments of mental illness, addictive disorders and CNS sequelae of infections. Current research focuses on the effects of methamphetamine and alcohol on brain function and the mechanism of neurocognitive deficits post COVID infection.
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Psychiatry, 1981 - 1985
University of Wisconsin School of Medicine & Public HealthClass of 1981
Certifications & Licensure
OR State Medical License 1982 - 2025
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Neurobiology of Alcohol and Nicotine Co-Addiction Start of enrollment: 2018 Feb 08
- Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users Start of enrollment: 2019 May 01
Publications & Presentations
PubMed
- 5 citationsCognition during active methamphetamine use versus remissionMarilyn Huckans, Stephen J. Boyd, Grant Moncrief, Nathan Hantke, Bethany Winters
Journal of Clinical and Experimental Neuropsychology. 2021-10-06 - 14 citationsDopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment.Milky Kohno, Laura E. Dennis, Holly D. McCready, William F. Hoffman
Molecular Psychiatry. 2021-06-11 - 4 citationsIntranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial.Christopher S Stauffer, Salem Samson, Alex Hickok, William F Hoffman, Steven L Batki
Frontiers in Psychiatry. 2021-01-01
Press Mentions
MediciNova Announces Collaboration with the U.S. Department of Veterans Affairs and Oregon Health & Science University to Evaluate MN-166 (Ibudilast) in Methamphetamine Use DisorderNovember 9th, 2017
Depression Treatment Center OregonNovember 1st, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
